ALDX

Aldeyra Therapeutics, Inc.$1.91-0.02 (-1.04%)

Prev Close$1.93·MCap$93.3M·P/E—·Vol684.9K·Yield—

▲

Buys (12M)

$536.8K

▼

Sells (12M)

$113.7K

◆

Net Activity

Net Buyer

$423.1K

●

Active Insiders

last 12 mo

Over the past 12 months, insider activity at Aldeyra Therapeutics, Inc. (ALDX) has been dominated by buying, with 4 insider purchases totaling $536.8K and 1 insider sale totaling $113.7K. The most recent insider transaction was by Brady Todd C (director, officer: President and CEO), who purchased $418.4K worth of shares on Jun 5, 2026. Aldeyra Therapeutics, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $93.3M.

ALDX Insider Trading Activity

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Jun 5, 2026	Brady Todd C	director, officer: President and CEO	Buy	250,000	$1.67	$418.4K	1,721,298
Mar 20, 2026	DOUGLAS RICHARD	director	Buy	70,000	$1.40	$98.0K	195,000+56%
Mar 19, 2026	Alfieri Michael	officer: Principal Financial Officer	Buy	5,000	$1.42	$7.1K	7,500+200%
Aug 13, 2025	Alfieri Michael	Principal Financial Officer	Buy	2,500	$5.30	$13.3K	0
Aug 11, 2025	Machatha Stephen	Chief Development Officer	Sell	22,073	$5.15	$113.7K	0
Aug 12, 2024	Greenberg Bruce	See Remarks	Sell	10,834	$4.74	$51.3K	0
Aug 12, 2024	Machatha Stephen	Chief Development Officer	Sell	16,041	$4.74	$76.0K	0
Mar 9, 2024	Brady Todd C	President and CEO	Sell	183,238	$3.17	$580.8K	0
Mar 9, 2024	Greenberg Bruce	See Remarks	Sell	13,201	$3.41	$45.0K	0
Mar 9, 2024	Machatha Stephen	Chief Development Officer	Sell	29,768	$3.31	$98.6K	0
Sep 7, 2023	Brady Todd C	President and CEO	Sell	73,807	$7.22	$532.9K	0
Jun 23, 2022	Brady Todd C	President and CEO	Buy	17,700	$3.36	$59.5K	0
Jun 23, 2022	JOYCE MARTIN JOSEPH	Director	Buy	4,323	$3.48	$15.0K	0
May 3, 2021	Miller-Rich Nancy	Director	Buy	922	$11.33	$10.4K	0

ALDX Insider Buying Activity

The following table shows recent insider purchases of Aldeyra Therapeutics, Inc. (ALDX) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Jun 5, 2026	Brady Todd C	director, officer: President and CEO	Buy	250,000	$1.67	$418.4K	1,721,298
Mar 20, 2026	DOUGLAS RICHARD	director	Buy	70,000	$1.40	$98.0K	195,000+56%
Mar 19, 2026	Alfieri Michael	officer: Principal Financial Officer	Buy	5,000	$1.42	$7.1K	7,500+200%
Aug 13, 2025	Alfieri Michael	Principal Financial Officer	Buy	2,500	$5.30	$13.3K	0
Jun 23, 2022	Brady Todd C	President and CEO	Buy	17,700	$3.36	$59.5K	0
Jun 23, 2022	JOYCE MARTIN JOSEPH	Director	Buy	4,323	$3.48	$15.0K	0
May 3, 2021	Miller-Rich Nancy	Director	Buy	922	$11.33	$10.4K	0

ALDX Insider Selling Activity

The following table shows recent insider sales of Aldeyra Therapeutics, Inc. (ALDX) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value
Aug 11, 2025	Machatha Stephen	Chief Development Officer	Sell	22,073	$5.15	$113.7K
Aug 12, 2024	Greenberg Bruce	See Remarks	Sell	10,834	$4.74	$51.3K
Aug 12, 2024	Machatha Stephen	Chief Development Officer	Sell	16,041	$4.74	$76.0K
Mar 9, 2024	Brady Todd C	President and CEO	Sell	183,238	$3.17	$580.8K
Mar 9, 2024	Greenberg Bruce	See Remarks	Sell	13,201	$3.41	$45.0K
Mar 9, 2024	Machatha Stephen	Chief Development Officer	Sell	29,768	$3.31	$98.6K
Sep 7, 2023	Brady Todd C	President and CEO	Sell	73,807	$7.22	$532.9K